These findings suggest that osteoglycin plays a key role mainly in insulin resistance and could indirectly participate in the development of atherosclerotic process through activation of the ATX/LPA pathway and proliferation of VSMCs within the population with T2D. The gene discussed is ENPP2; the disease is Insulin resistance.